Verona Pharma's total assets for Q3 2024 were $381.82M, a decrease of -12.05% from the previous quarter. VRNA total liabilities were $251.33M for the fiscal quarter, a -5.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.